Skip to main content
HR 2315 113th Congress House

Preserving Access to Orphan Drugs Act of 2013

Official title: To clarify the orphan drug exception to the annual fee on branded prescription pharmaceutical manufacturers and importers.

Introduced: May 1, 2014 See on congress.gov
Health Health care costs and insurancePrescription drugsUser charges and fees
Sign in to write a letter Sign in to watch
This bill died when the 113th Congress ended
It never became law before the 113th Congress (2013–2014) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 25, 2013
Rereferred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 14, 2013
Referred to the Subcommittee on Health.
Jun 11, 2013
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 11, 2013
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action July 25, 2013

Rereferred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

 Plain-English summary Congressional Research Service

Preserving Access to Orphan Drugs Act of 2013 - Amends the Patient Protection and Affordable Care Act (PPACA) to exclude any drug or biological product which is approved or licensed by the Food and Drug Administration (FDA) for marketing solely for one or more rare diseases or conditions (orphan drug) from the annual fee on manufacturers or importers with branded prescription drug sales exceeding $5 million.

Makes this Act effective as if included in PPACA.

 Related & companion bills 1
  • S 1128 Identical bill Preserving Access to Orphan Drugs Act of 2013
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 3
 Cosponsors 39
All 39 Democratic 5 Republican 5
Bishop, Timothy
· Sep 18, 2014
 D
Thompson, Mike
California · Sep 8, 2014
SHIMKUS, JOHN
· Jul 10, 2014
Long, Billy
· May 29, 2014
Schock, Aaron
· May 28, 2014
Rothfus, Keith
· May 20, 2014
Murphy, Tim
· May 8, 2014
Black, Diane
· May 1, 2014
KING, PETER
· Mar 25, 2014
TIBERI, PATRICK
· Mar 21, 2014
Loebsack, David
· Mar 11, 2014
 D
Cohen, Steve
Tennessee · Mar 6, 2014
Schrader, Kurt
· Feb 27, 2014
Boustany, Charles
· Feb 26, 2014
Brooks, Susan
· Jan 21, 2014
 D
Frankel, Lois
Florida · Jan 21, 2014
Rokita, Todd
· Dec 12, 2013
Dent, Charles
· Nov 15, 2013
LATHAM, TOM
· Nov 14, 2013
 R
McCaul, Michael T.
Texas · Nov 13, 2013
Renacci, James
· Nov 13, 2013
WOLF, FRANK
· Nov 13, 2013
 R
Young, Todd
Indiana · Oct 16, 2013
Marchant, Kenny
· Oct 10, 2013
Lance, Leonard
· Oct 8, 2013
 R
Guthrie, Brett
Kentucky · Oct 2, 2013
Jenkins, Lynn
· Sep 23, 2013
Meehan, Patrick
· Sep 23, 2013
 R
Kelly, Mike
Pennsylvania · Sep 18, 2013
ENGEL, ELIOT
· Sep 10, 2013
Nunes, Devin
· Sep 10, 2013
Owens, William
· Aug 2, 2013
Polis, Jared
· Jul 30, 2013
Paulsen, Erik
· Jul 24, 2013
Kinzinger, Adam
· Jul 17, 2013
 R
Thompson, Glenn
Pennsylvania · Jul 16, 2013
 D
Carson, André
Indiana · Jul 10, 2013
Schwartz, Allyson
· Jul 10, 2013
 D
Neal, Richard E.
Massachusetts · Jun 11, 2013
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2315: Preserving Access to Orphan Drugs Act of 2013. 113th Congress. Open America. https://openamerica.io/bill/113-HR-2315/
MLA
"H.R. 2315: Preserving Access to Orphan Drugs Act of 2013." 113th Congress, 2026, Open America, https://openamerica.io/bill/113-HR-2315/.
Bluebook (legal)
H.R. 2315, 113th Cong. (2026), https://openamerica.io/bill/113-HR-2315/.
Markdown link
[H.R. 2315: Preserving Access to Orphan Drugs Act of 2013](https://openamerica.io/bill/113-HR-2315/)
Report a problem